BETTER THERAPEUTICS INC (BTTX) Stock Analyst Earnings Estimates
NASDAQ:BTTX - Nasdaq - US08773T1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 12.56% | N/A 258.65% | N/A 192.68% | N/A 3,293.09% | N/A 27.99% | N/A 12.87% | ||||
| EBITDA YoY % growth | N/A | -28.94M | -35.53M -22.77% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30.56M | -38.26M -25.20% | N/A 27.75% | N/A -75.65% | N/A 33.24% | N/A 38.30% | N/A 38.16% | N/A 4,745.72% | N/A 47.33% | N/A 21.44% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.68 49.05% | N/A 50.82% | N/A -23.46% | N/A -8.00% | N/A 36.11% | N/A 34.78% | N/A | N/A | N/A |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 66.92% | -0.21 45.08% | -0.20 17.12% | -0.20 -36.00% | -0.20 -62.50% | -0.28 -28.57% | -0.26 -28.21% | -0.24 -20.00% | -0.22 -12.82% |
| Revenue Q2Q % growth | 69.36K | 174.93K | 236.64K | 294.27K | 2.101M 2,929.12% | 2.663M 1,422.32% | 3.258M 1,276.77% | 3.885M 1,220.22% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.916M 28.89% | -7.387M 17.28% | -7.519M -6.96% | -7.59M -42.10% | -8.208M -38.74% | -6.232M 15.63% | -5.847M 22.25% | -5.432M 28.44% | -4.986M 39.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.15 68.75% | -0.20 | 0.05 | 24.59% |
| Q2 2023 Q2Q % growth | -0.24 42.86% | -0.32 | 0.08 | 24.71% |
| Q1 2023 Q2Q % growth | -0.39 4.88% | -0.76 | 0.37 | 48.68% |
| Q4 2022 Q2Q % growth | -0.37 47.89% | -0.52 | 0.15 | 28.41% |
| Q3 2022 Q2Q % growth | -0.48 -1,500.00% | -0.49 | 0.01 | 1.28% |
| Q2 2022 Q2Q % growth | -0.42 | -0.46 | 0.04 | 8.50% |
| Q1 2022 Q2Q % growth | -0.41 | -0.39 | -0.02 | -4.41% |
| Q4 2021 Q2Q % growth | -0.71 | -0.47 | -0.24 | -52.42% |
| Q3 2021 Q2Q % growth | -0.03 | -1.69 | 1.66 | 98.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |